Please login to the form below

Not currently logged in
Email:
Password:

Sygnature Discovery

This page shows the latest Sygnature Discovery news and features for those working in and with pharma, biotech and healthcare.

Latest appointments

  • Dr Edward Browne joins Sygnature Discovery Dr Edward Browne joins Sygnature Discovery

    Dr Edward Browne joins Sygnature Discovery. He becomes associate director of drug metabolism and pharmacokinetics. ... Dr Timothy Schulz-Utermoehl, director of DMPK at Sygnature Discovery, said: “ I am delighted to welcome Ed to the team here at

  • Sygnature Discovery expands business and bioscience teams Sygnature Discovery expands business and bioscience teams

    Sygnature Discovery has appointed Dr Stephen Young and Dr Stuart Thomson to its senior business and bioscience teams. ... Meanwhile, Dr Stuart Thomson (pictured left) joins Sygnature Discovery as associate director of bioscience.

  • Industry veteran Louis Nisbet joins Sygnature board Industry veteran Louis Nisbet joins Sygnature board

    Industry veteran Louis Nisbet joins Sygnature board. Brings experience from Roche, Glaxo and SmithKline. ... Sygnature Discovery has appointed Dr Louis Nisbet to its board as a non-executive director.

More from appointments
Approximately 2 fully matching, plus 1 partially matching documents found.

Featured jobs

Subscribe to our email news alerts

PMHub

Add my company
Health Unlimited

Health Unlimited is a global health consultancy and communications agency built by specialists with unmatched experience, perspective and expertise. For...

Latest intelligence

The threat of antimicrobial resistance
Why this issue is such a fundamental challenge...
Meet the CEO behind ReNeuron’s cutting-edge stem cell therapies
Blue Latitude Health speaks to Olav Hellebo, CEO of ReNeuron, to find out about the biotech’s latest innovation in stem cell therapy and to learn his perspective on navigating the...
Unique forum will unite NHS and industry to drive innovation
HSJ Life Sciences Forum will explore key NHS challenges and debate future of medicines, by Sarah Eglington, Client Services Director at Wilmington Healthcare...

Infographics